Cipro and Melphalan drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Cipro (ciprofloxacin hydrochloride) and Melphalan (melphalan). Common drug interactions include bone disorder among females and prostate cancer among males.
The phase IV clinical study analyzes what interactions people have when they take Cipro and Melphalan. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.
What is Cipro?
Cipro has active ingredients of ciprofloxacin hydrochloride. It is often used in urinary tract infection. eHealthMe is studying from 35,126 Cipro users. Check the latest studies of Cipro.
What is Melphalan?
Melphalan has active ingredients of melphalan. eHealthMe is studying from 20,052 Melphalan users. Check the latest studies of Melphalan.
33 people who take Cipro and Melphalan together, and have interactions are studied.

What are the common drug interactions of Cipro and Melphalan, by gender? *:
female:
- Bone disorder
- Deformity (disfigurement)
- Depression
- Emotional distress
- Gait disturbance
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Hyperlipidaemia (presence of excess lipids in the blood)
- Osteopenia (a condition where bone mineral density is lower than normal)
- Pain
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
male:
- Prostate cancer
- Dyspnoea (difficult or laboured respiration)
- Hypersensitivity
- Osteolysis (dissolution of bone)
- Osteonecrosis of jaw (death of bone of jaw)
- Osteopenia (a condition where bone mineral density is lower than normal)
- Pain
- Pain in jaw
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Periorbital oedema (swelling around the eyes)
What are the common drug interactions of Cipro and Melphalan, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Dyspnoea (difficult or laboured respiration)
- Anxiety
- Bone disorder
- Deformity (disfigurement)
- Depression
- Emotional distress
- Gait disturbance
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Hyperlipidaemia (presence of excess lipids in the blood)
- Intervertebral disc degeneration (spinal disc degeneration)
50-59:
- Death
- Decreased appetite
- Escherichia bacteraemia (presence of bacteria escherichia coli in the blood)
- Mucosal inflammation (infection of mucous membrane)
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Plasma cell myeloma (cancer that begins in plasma cells)
- Platelet count decreased
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Bacteraemia (presence of bacteria in the blood)
- Diarrhoea
60+:
- Prostate cancer
- Dyspnoea (difficult or laboured respiration)
- Hypersensitivity
- Osteolysis (dissolution of bone)
- Osteonecrosis of jaw (death of bone of jaw)
- Osteopenia (a condition where bone mineral density is lower than normal)
- Pain
- Pain in jaw
- Periorbital oedema (swelling around the eyes)
- Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)
What are the existing conditions these people have? *
- Multiple Myeloma (cancer of the plasma cells): 23 people, 69.70%
- High Blood Pressure: 6 people, 18.18%
- Nausea (feeling of having an urge to vomit): 6 people, 18.18%
- Pain: 5 people, 15.15%
- Depression: 4 people, 12.12%
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 3 people, 9.09%
- Haematopoietic Stem Cell Mobilisation: 3 people, 9.09%
- Back Pain: 3 people, 9.09%
- Constipation: 3 people, 9.09%
- Dyspnea (difficult or laboured breathing): 3 people, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Cipro and Melphalan?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Cipro and Melphalan:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cipro:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Melphalan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cipro and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Melphalan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on ciprofloxacin hydrochloride and melphalan (the active ingredients of Cipro and Melphalan, respectively), and Cipro and Melphalan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Cefzil and Coumadin - now
- Could Mucinex Dm cause Back Pain? - a second ago
- Could Digoxin cause White Blood Cell Count Decreased? - 2 seconds ago
- Transplant and Red Blood Cell Count Decreased - 9 seconds ago
- Could Ibu cause Progesterone Decreased? - 14 seconds ago
- Could Cabometyx cause Hiccups? - 17 seconds ago
- Drug interactions of Doxazosin Mesylate and Ciprofloxacin - 25 seconds ago
- Drug interactions of Zide and Hydrocodone - 50 seconds ago
- Drug interactions of Claritin and Ditropan - a minute ago
- Could Albuterol Sulfate cause Cerebral Atrophy? - a minute ago